Raj Makkar, the doctor at Cedars-Sinai Heart Institute in Los Angeles leading the study, wanted to know how widespread this was. In a report published Monday by the New England Journal of Medicine, he and others say the problem has now been found in 22 of 55 of patients in the study, and in 17 of 132 of patients in two registries tracking tissue valve recipients.» Read More
John Hancock aims to use wearables to track policyholders' activity, using the information to provide differential pricing on insurance policies.
April 17- The U.S. Food and Drug Administration approved AcuFocus Inc's corneal implant to improve vision in patients with presbyopia, an age-related eye disorder. The device, KAMRA inlay, is the first implantable device to correct vision in patients who have not had cataract surgery, the FDA said in a statement on Friday. The FDA, however, warned that the device...
April 17- The U.S. Food and Drug Administration approved AcuFocus Inc's corneal implant to improve vision in patients with presbyopia, an age-related eye disorder. The device, KAMRA inlay, is the first implantable device to correct vision in patients who have not had cataract surgery, the FDA said in a statement on Friday. Presbyopia is a condition associated...
NEW YORK, April 12- Medical researchers call it the "Angelina Effect," the surge in demand for genetic testing attributable to movie star Angelina Jolie's public crusade for more aggressive detection of hereditary breast and ovarian cancer. But there's a catch: Major insurance companies including Aetna, Anthem and Cigna are declining to pay for the latest...
CNBC Crowdfinance Tech Index lists the largest capital commitments raised by 25 private U.S. tech companies on Crowdnetic’s data platform.
Dan Mahony, fund manager at Polar Capital, tells CNBC how to be a "smart healthcare investor".
George Freeman MP, minister of life sciences in the U.K., says there's been a "resurgence" for life sciences and healthcare investment.
How much would it cost world governments to insulate their economies from global pandemics. Would you believe nearly $344 billion?
A flu shot that lasts 10 years could be a reality soon, a top hospital executive told CNBC, along with "real steps" toward a cancer vaccine.
Analysts are expecting a jump in earnings growth from the healthcare sector, but will its success continue into 2015? Andrew Burkly, managing director and head of institutional portfolio strategy at Oppenheimer Asset Management, shares his thoughts.
Despite the endless controversies dogging Obamacare, the CEO of Mount Sinai believes the legislation is meeting many of its goals.
The first trial of an Ebola vaccine has started with the vaccination of three health care workers in Mali, researchers told NBC News.
Another day, another new wrist-wearable in gadgetland. But this one sounds … pretty compelling. Re/code explains.
The death toll from the Ebola virus in West Africa keeps growing to record levels. And ironically, that may be why there's no vaccine, said an expert.
A David taking on retail Golaiths, this e-commerce upstart is circumventing traditional channels and selling eyeglasses to the masses.
One of the world's largest makers of medical devices, Medtronic, is considering a takeover of London-based Smith & Nephew, Bloomberg said.
As AstraZeneca's shares slid following its rejection of Pfizer's new bid, the company's chairman said he was "reasonably confident" it was the right decision.
Boston Scientific received a subpoena this week from the Department of Health and Human Services seeking information about its defibrillators.
Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.
The Gates Foundation has awarded $2 million in grants to several Indian organizations to help improve sanitation by building a high-tech toilet.